KH

Kitty Hawk Capital

North America, North Carolina, United States, Charlotte

Description

Kitty Hawk Capital has provided venture capital financing to more than 70 private companies since 1980.

Investor Profile

Kitty Hawk Capital has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Electronics, FinTech.

Stage Focus

  • Series B (50%)
  • Series Unknown (17%)
  • Series A (17%)
  • Series E (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Electronics
  • Fintech
  • Information Technology
  • Mobile
  • Professional Networking
  • Wireless
  • Health Care
  • Medical
  • Network Security
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kitty Hawk Capital frequently co-invest with?

Anthem Capital Management
North America, Maryland, United States, Baltimore
Co-Investments: 2
Wakefield Group
North America, North Carolina, United States, Charlotte
Co-Investments: 2
Dow
North America, Michigan, United States, Midland
Co-Investments: 1
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
Dogwood Equity
North America, North Carolina, United States, Raleigh
Co-Investments: 1
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 3
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 1
AC
North America, North Carolina, United States, Durham
Co-Investments: 1
Quaker BioVentures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Mid-Atlantic Venture Funds
North America, Pennsylvania, United States, Bethlehem
Co-Investments: 2

What are some of recent deals done by Kitty Hawk Capital?

Synageva BioPharma

Waltham, Massachusetts, United States

Synageva, a biopharmaceutical company, develops and commercializes novel, next generation and follow on protein therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Series EAug 20, 2008
Amount Raised: $17,170,000
Biolex Therapeutics

Pittsboro, North Carolina, United States

Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.

BiotechnologyHealth CareMedical
Series BSep 1, 2005
Amount Raised: $36,000,000
Biolex Therapeutics

Pittsboro, North Carolina, United States

Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.

BiotechnologyHealth CareMedical
Series UnknownAug 21, 2003
Amount Raised: $24,400,000
NetOctave

Morrisville, North Carolina, United States

NetOctave develops silicon-based network security solutions.

Network Security
Series BFeb 11, 2002
Amount Raised: $7,800,000
ScoreBoard

Herndon, Virginia, United States

ScoreBoard, a provider of network management solutions for the wireless last mile.

ElectronicsFinTechInformation TechnologyMobileProfessional NetworkingWireless
Series BJul 21, 2000
Amount Raised: $25,000,000
ScoreBoard

Herndon, Virginia, United States

ScoreBoard, a provider of network management solutions for the wireless last mile.

ElectronicsFinTechInformation TechnologyMobileProfessional NetworkingWireless
Series ASep 14, 1999
Amount Raised: $4,200,000